🖼
Figure 1 — Extracellular vesicles and miRNA-based therapies in triple-negative breast cance
active
paper figure
Created: 2026-04-21T18:29:40
By: paper_figures_tool
Quality:
50%
🔗 External
ID: paper-fig-4e976abc-bd95-4542-bda2-0c9351
Figure 1Figure 1
Quantitative breakdown of topics in reviewed studies on MSC-derived EV therapy. Quantitative analysis of the systematic review by Mizenko et al . (2024) involving clinical trials related to EVs and cited in this article [ 126 ] . Analysis of the distribution of prevalent topics in the studies, such as diagnosis, complementary diagnosis, and therapeutic, as well as the main sources of MSC-derived EVs used. Graph Pad Prism 8.0.2. MSCs: Mesenchymal stem cells; EVs: extracellular vesicles.
▸Metadata
| pmid | 4e976abc-bd95-4542-bda2-0c93515e37d5 |
| caption | Quantitative breakdown of topics in reviewed studies on MSC-derived EV therapy. Quantitative analysis of the systematic review by Mizenko et al . (2024) involving clinical trials related to EVs and c |
| image_url | https://www.ebi.ac.uk/europepmc/articles/PMC11977377/bin/evcna-6-1-54.fig.1.jpg |
| paper_title | Extracellular vesicles and miRNA-based therapies in triple-negative breast cancer: advances and clinical perspectives. |
| figure_label | Figure 1 |
| figure_number | 1 |
| _schema_version | 1 |
| source_strategy | pmc_api |
📊 Evidence Profile
Evidence Balance
+0%
Certainty
0%
Debates
0
Incoming
0
Outgoing
0
0 supporting
0 contradicting
0 neutral
Public annotations (0)Annotate on Hypothes.is →
No public annotations yet.